Evidence map›Paper›PMID 40190370›Full record

ReviewNeuro-ophthalmology (Aeolus Press)2025

The Characteristics and Visual Outcomes of Dialysis-Associated Non-Arteritic Ischemic Optic Neuropathy: A Comprehensive Systematic Review.

Hashem Abu Serhan, Abdulla Shaheen, Ahmed Maher, Ibrahim Samir Abdel-Bary, Masoud Rahimi, Mohammad Samara, Ameen Alkhateeb, Anas S R Dalloul, Amr M EElemary, Ayman G Elnahry

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Neuro-ophthalmology (Aeolus Press), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hashem Abu SerhanDepartment of Ophthalmology, Hamad Medical Corporation, Doha, Qatar.
Abdulla ShaheenBascom Palmer Eye Institute, University of Miami, Miami, Florida, USA.
Ahmed MaherFaculty of Medicine, Al-Azhar University, New-Damietta, Egypt.
Ibrahim Samir Abdel-BaryFaculty of Medicine, Tanta University, Tanta, Egypt.
Masoud RahimiRetina Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad SamaraDepartment of Ophthalmology, Hamad Medical Corporation, Doha, Qatar.
Ameen AlkhateebDepartment of Ophthalmology, Hamad Medical Corporation, Doha, Qatar.
Anas S R DalloulDepartment of Ophthalmology, Hamad Medical Corporation, Doha, Qatar.
Amr M EElemaryNational Eye Center, Ministry of Health and Population, Cairo, Egypt.
Ayman G ElnahryDepartment of Ophthalmology, Faculty of Medicine, Cairo University, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-arteritic ischemic optic neuropathy (NAION) is a common cause of sudden, painless vision loss, often triggered by inadequate blood supply. Dialysis, essential for end-stage renal disease (ESRD), can precipitate intradialytic hypotension, potentially leading to dialysis-associated NAION (DA-NAION). Our protocol was prospectively registered on PROSPERO (CRD42023464202). On 12 December 2023, five databases were searched: PubMed, Scopus, Web of Science, Google Scholar, and Cochrane. We have included all primary studies reporting NAION post-dialysis. Data about baseline characteristics, dialysis types, and NAION were extracted. From 250 identified papers, 24 studies involving 36 patients were included. Patients with DA-NAION presented at a younger age compared to non-dialysis NAION cases. Patients on continuous peritoneal dialysis (CPD) were significantly younger by about 17 years compared to those on hemodialysis. Visual outcomes were generally poor, with an average best corrected visual acuity (BCVA) of 1.33 logMAR (20/428 Snellen). Bilateral involvement was more common in CPD patients (100%) compared to hemodialysis patients (37.5%) (

Indexed as

DialysishemodialysishypotensionNAIONrenal replacement therapyvisual loss

Identifiers

PMID40190370
PMCPMC11970738

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.